A Summary of the Issue
Nowadays, the HIV pandemics are not over yet. Even though scientists try to find a way to fight the illness, the general lethal outcome is relatively high. The tendency of HIV and AIDS diseases has a growing character, so additional political and regulatory means to lower the death rate are required. The issue of HIV and AIDS prevention is directly connected with determining the efficient country’s policy. This problem influencing many spheres of human life is highly debatable nowadays and requires additional consideration and mindful state regulation.
Background Information
According to the history of the legislation and regulation of the AIDS and HIV pandemics, there were different ways to perform the treatment and preventing services. Beurer (2021) believes that the US policy regarding AIDS and HIV pandemics was active primarily during the virus’s spread crisis. The author emphasizes that under the Republican government, the virus-preventing policy is more developed than under the Democratic administration (Padamsee, 2018). This practical research also indicated that the history of the AIDS/HIV legislation lacks people awareness and virus prevention programs (Padamsee, 2018). Thus, to improve public health, the government needs to develop a fully-angled policy that includes illness treatment programs and virus prevention.
Policy Options
Due to the investments into the sphere, the bill can have an excellent profit for the AIDS/HIV treatment and provide infected people with comfortable living conditions. The main disadvantage of the proposed legislation is that it is mainly oriented on investments in treatment while leaving behind the development of HIV and AIDS prevention measures. The main channel of infection in the human body is direct blood implementation (Benzaken, 2019). Therefore, it is essential to ensure the quality of the potentially dangerous medical procedures. According to practical research, there is a direct correlation between poor treatment service and AIDS/HIV spreading (Padamsee, 2018). Thus, the needle exchange service and programs may be one of the crucial directions for development.
Another policy option to be considered is the investment in the AIDS/HIV awareness of the citizens. The appropriate law reform to ensure that the people are aware of how to avoid getting infected or where to seek help when being in a dangerous situation will significantly help stop spreading the infection and lower the rates of infected people (Beyrer, 2021). Thus, the government should create particular programs to perform these activities.
The proposed policy options also have particular disadvantages. The government needs to find a considerable amount of money to cover all the spendings to perform the mentioned policies. It can be challenging to achieve the total complex of the events because of the expenditure. Thus, the government will focus on the one particular direction which is the most crucial for the specific moment. This definitely the improvement of the medical treatment for infected people. Thus, these policy options should be considered only in the long-term perspective.
Stakeholder Perspectives
All the people can be considered stakeholders because everyone is getting infected without proper healthcare development investments. Speaking about people with AIDS and HIV, they are will have no profits out of these options. However, the proposed bill itself respects their rights and implies investments for the illness’s treatment. People who do not have AID/HIV will definitely have a positive attitude towards the policy options because these lower the risk of accidental contamination through the medical services improvements.
Recommendations
The recommended actions are to develop unique citizen awareness of AIDS/HIV programs and ensure the medical services improvements to exterminate the main channel of contamination.
References
Beyrer, C. (2021). A pandemic anniversary: 40 years of HIV/AIDS. The Lancet, 397(10290), 2142–2144. Web.
Padamsee, J. (2020). Fighting an epidemic in political context: Thirty-five years of HIV/AIDS policy making in the United States. Social History of Medicine, 33(3), 1001–1028. Web.
Benzaken, A, Costa, L., Pereira, G., Tanuri, A., Santos, A. & Soares, M. (2019). Antiretroviral treatment, government policy and economy of HIV/ AIDS in Brazil. AIDS Research and Theraphy, 16(19), 12-34. Web.